Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11655285 Human immunodeficiency virus neutralizing antibodies

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Gilead Sciences

0

Current Assignee

Gilead Sciences

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

May 23, 2023

0

Patent Application Number

171108760

Date Filed

December 3, 2020

0

Patent Citations

US Patent 8394925 Fc variants with altered binding to FcRn

0

US Patent 8546543 Fc variants that extend antibody half-life

0

US Patent 8840890 Rapid expression cloning of human monoclonal antibodies from memory B cells

0

US Patent 8937158 Fc variants with increased affinity for FcγRIIc

0

US Patent 9040041 Modified FC molecules

0

US Patent 9353187 Optimized FC variants and methods for their generation

0

US Patent 9464131 Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody

0

US Patent 9803023 Fc variants with altered binding to FcRn

0

...

Patent Primary Examiner

Nicole Kinsey White

0

The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11655285 Human immunodeficiency virus neutralizing antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool